Sihuan Pharmaceutical Gr... (SHPHF)

AI Score

Unlock

0.12

-0.00 (-1.48%)

At close: Apr 23, 2025, 8:00 PM

Sihuan Pharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Cash & Equivalents	4.01B	3.89B	3.73B	3.83B	5.1B	5.68B	4.63B	4.6B	4.95B	5.12B	4.94B	3.31B	1.46B	831.86M	1.61B	2.41B	2.68B
Short-Term Investments	854.39M	589.02M	775.96M	962.99M	150.31M	109.3M	679.23M	332.68M	420.85M	148.34M	562.16M	1.3B	2.79B	2.97B	2.21B	1.71B	2.48B
Long-Term Investments	747.26M	1B	869.58M	907.34M	1.03B	972.53M	1.4B	1.27B	1.16B	1.26B	1.36B	1.35B	1.17B	1.05B	1.35B	1.29B	1.2B
Other Long-Term Assets	454.32M	676.17M	-45.87M	-96.77M	-282.87M	-303.46M	-312.95M	-269.45M	-293.27M	-332.22M	-341.66M	-111.11M	-195.38M	-127.51M	-114.18M	-35.88M	-21.97M
Receivables	537.72M	397.82M	482.02M	522.25M	827.76M	779.07M	834.67M	389.82M	273.27M	292.2M	505.26M	476.74M	388.46M	458.44M	595.42M	591.19M	422.42M
Inventory	475.41M	557.32M	615.29M	606.7M	700.68M	715.3M	565.71M	495.89M	439.71M	409.6M	365.1M	301.12M	282.01M	227.97M	228.51M	200.68M	265.89M
Other Current Assets	862.51M	880.93M	771.33M	629.59M	666.15M	455.36M	456.53M	581.72M	862.79M	337.87M	309.93M	380.44M	284.68M	288.7M	375.22M	286.07M	324.57M
Total Current Assets	6.74B	6.2B	6.38B	6.55B	7.44B	7.74B	7.17B	6.4B	6.94B	6.31B	6.68B	5.78B	5.2B	4.77B	5.02B	5.19B	6.18B
Property-Plant & Equipment	2.78B	2.84B	2.91B	3B	4.14B	4.09B	3.91B	3.84B	3.61B	3.62B	2.78B	2.78B	2.91B	2.45B	2.2B	2.1B	2.06B
Goodwill & Intangibles	803.35M	777.82M	700.92M	595.96M	664.29M	459.97M	684.74M	323.23M	560.74M	285.23M	2.06B	3.94B	4.96B	3.8B	4.68B	3.19B	2.8B
Total Long-Term Assets	4.79B	5.33B	4.48B	4.5B	5.83B	5.53B	5.99B	5.43B	5.33B	5.17B	6.2B	8.07B	9.03B	7.31B	8.23B	6.59B	6.06B
Total Assets	11.53B	11.54B	11.77B	12.14B	14.41B	14.5B	14.31B	13.04B	13.12B	12.57B	13.76B	15.44B	14.69B	13.59B	13.5B	12.19B	13.05B
Account Payables	215.87M	220.61M	186.48M	205.78M	167.49M	118.91M	124.31M	106.2M	58.88M	65.72M	57.59M	37.2M	34.59M	34.32M	118.12M	82.66M	148.26M
Deferred Revenue	n/a	1.68B	-258.76M	-340.26M	-461.28M	-205.19M	-147.89M	-393.37M	-516.12M	-4.06M	-4.22M	-59.42M	-127.76M	n/a	-3.5M	-8.28M	-51.4M
Short-Term Debt	227.52M	269.68M	239.92M	340.97M	449.92M	200M	146.07M	391.93M	514.98M	n/a	597K	n/a	181.15M	180.75M	132.37M	66.51M	n/a
Other Current Liabilities	3.2B	1.93B	1.26B	1.27B	1.47B	1.1B	1.25B	957.43M	2.12B	982.28M	1.07B	1.19B	978.28M	948.77M	1.9B	726.65M	1.24B
Total Current Liabilities	4.12B	4.11B	2.24B	2.53B	3.06B	2.5B	2.61B	2.44B	3.79B	2.26B	2.71B	2.25B	2.28B	1.9B	2.47B	1.04B	1.51B
Long-Term Debt	859.23M	905.03M	1.04B	848.67M	670.24M	844.75M	665.86M	359.17M	72.84M	9M	n/a	95M	83.14M	n/a	n/a	n/a	8.28M
Other Long-Term Liabilities	1.44B	1.12B	-36.64M	-45.86M	-47.12M	-31.46M	-1.59M	-585.88M	-2.01M	-718.92M	12.31M	n/a	n/a	88.08M	n/a	1.00	n/a
Total Long-Term Liabilities	2.32B	2.29B	1.04B	848.67M	670.24M	844.75M	665.86M	359.17M	72.84M	9M	19M	95M	83.14M	352.48M	344.93M	178.02M	8.28M
Total Liabilities	6.44B	6.4B	6.52B	6.5B	6.31B	5.35B	3.63B	3.1B	4.18B	2.63B	3.04B	2.67B	2.69B	2.26B	2.82B	1.22B	1.67B
Total Debt	1.12B	1.26B	1.33B	1.19B	1.18B	1.08B	815.34M	755.05M	590.97M	18.95M	10.9M	95M	210.91M	n/a	3.5M	8.28M	8.28M
Common Stock	77.06M	77.06M	77.06M	77.06M	77.06M	77.06M	78.07M	78.19M	78.19M	78.19M	78.19M	78.23M	78.23M	78.23M	78.23M	79.44M	85.13M
Retained Earnings	897.51M	946.34M	956.18M	1.69B	3.58B	4.92B	4.79B	4.63B	4.27B	5.57B	6.04B	8.49B	7.38B	7.01B	6.3B	6.61B	5.53B
Comprehensive Income	-387.96M	-439.76M	-475.82M	-913.86M	-276.9M	-597.15M	918.19M	398.83M	186.47M	-131.3M	163.07M	-150.41M	143.71M	-122.02M	140.42M	-131.79M	184.69M
Shareholders Equity	4.42B	4.43B	4.41B	4.74B	7.26B	8.28B	9.84B	9.19B	8.62B	9.61B	10.36B	12.51B	11.7B	11.06B	10.61B	10.9B	11.3B
Total Investments	1.6B	1B	1.65B	1.87B	1.18B	1.08B	2.08B	1.6B	1.58B	1.41B	1.93B	2.65B	3.96B	4.02B	3.56B	3B	3.69B